Literature DB >> 7472695

Use of pneumococcal vaccine.

D S Fedson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7472695     DOI: 10.1007/bf02599847

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  8 in total

1.  Update on adult immunization. Recommendations of the Immunization Practices Advisory Committee (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1991-11-15

Review 2.  The outpatient diagnosis and management of chronic obstructive pulmonary disease: pharmacotherapy, administration of supplemental oxygen, and smoking cessation techniques.

Authors:  R M Schapira; L F Reinke
Journal:  J Gen Intern Med       Date:  1995-01       Impact factor: 5.128

Review 3.  The pneumococcal vaccine after 15 years of use.

Authors:  J V Hirschmann; B A Lipsky
Journal:  Arch Intern Med       Date:  1994-02-28

4.  Pneumococcal vaccine after 15 years of use. Another view.

Authors:  D S Fedson; E D Shapiro; F M LaForce; M A Mufson; D M Musher; J S Spika; R F Breiman; C V Broome
Journal:  Arch Intern Med       Date:  1994-11-28

5.  Influenza and pneumococcal vaccination in the emergency department: is it feasible?

Authors:  K Wrenn; M Zeldin; O Miller
Journal:  J Gen Intern Med       Date:  1994-08       Impact factor: 5.128

6.  Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials.

Authors:  M J Fine; M A Smith; C A Carson; F Meffe; S S Sankey; L A Weissfeld; A S Detsky; W N Kapoor
Journal:  Arch Intern Med       Date:  1994 Dec 12-26

Review 7.  Pneumococcal vaccination in the prevention of community-acquired pneumonia: an optimistic view of cost-effectiveness.

Authors:  D S Fedson
Journal:  Semin Respir Infect       Date:  1993-12

8.  Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations.

Authors:  J C Butler; R F Breiman; J F Campbell; H B Lipman; C V Broome; R R Facklam
Journal:  JAMA       Date:  1993-10-20       Impact factor: 56.272

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.